Skip to main content
. 2023 Jan 3;12(1):366. doi: 10.3390/jcm12010366

Table 2.

Hazard Associated with each Standard Deviation Change in Peak Vo2.

Model 1 Univariate Model 2 Demographics Model 3 Clinical Covariates
HR § (95% CI) p-Value HR (95% CI) p-Value HR (95% CI) p-Value
Peak Oxygen Consumption Absolute Peak Vo2 (SD ± 414 mL O2/min) 0.75 (0.60, 0.93) 0.010 0.60 (0.46, 0.78) 0.000 0.62 (0.47, 0.81) 0.001
% Predicted Peak Vo2 (SD ± 14%) 0.66 (0.53, 0.84) 0.001 0.63 (0.50, 0.81) 0.000 0.68 (0.53, 0.87) 0.002
Peak Vo2, body mass (SD ± 4 mL O2/min/kg body mass) 0.69 (0.55, 0.87) 0.002 0.66 (0.52, 0.83) 0.000 0.72 (0.56, 0.91) 0.007
Peak Vo2, lean (SD ± 6 mL/min/kg lean mass) 0.62 (0.49, 0.78) 0.000 0.63 (0.50, 0.79) 0.000 0.68 (0.53, 0.86) 0.002
O2 Pulse (SD ± 3 mL O2/beat) 0.81 (0.65, 0.99) 0.043 0.66 (0.52, 0.85) 0.001 0.66 (0.51, 0.85) 0.002

Higher Peak Vo2 is associated with a decreased hazard of death or retransplantation. Model 1—unadjusted Cox proportional hazard model. Model 2—adjusted for age, race/ethnicity, sex, and days from transplant to CPET. Model 3—adjusted for Model 2 variables plus pulmonary vascular resistance, type 2 diabetes, ischemic cardiomyopathy, peripheral-vascular disease, chronic obstructive pulmonary disease, and hemoglobin. Hazard ratios (HR) are for a one standard deviation (SD) change in each metric. Acronyms: Vo2, oxygen consumption.